Agaricus muscarius 10M homeopathic granules
Official documents, adverse reaction reporting, and safety monitoring
Report a side effect
Submit a Yellow Card report to the MHRA
Safety monitoring data
Yellow Card reports
The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.
View Drug Analysis Profile
Browse all Drug Analysis Profiles A–Z
Browse all iDAP reports
Interactive Drug Analysis Profiles for all medicines
Report a side effect
Submit a Yellow Card report to the MHRA
Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.
EudraVigilance
The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.
Search EudraVigilance database
Browse substances A–Z in the European adverse reaction database
About EudraVigilance
Learn about EU pharmacovigilance and safety monitoring
EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.
1 branded products available
Therapeutically similar medicines
Similarity is based on WHO Anatomical Therapeutic Chemical (ATC) classification and on a factual NHS dm+d therapeutic-grouping code prefix. Source data: NHS dm+d via TRUD (OGL v3.0), WHO ATC/DDD Index.
NHS prescribing volume and spending trends
Check stock at pharmacies and supply information
Pharmacy stock checkers
Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.
Supply & safety information
Official UK regulator monitoring and safety alerts
Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. Shortage and safety information sourced from MHRA drug safety updates (gov.uk, Crown Copyright under OGL v3.0).
Codes for healthcare professionals and prescribing systems
These codes are used by healthcare IT systems and prescribers to identify this medicine.
NHS UK identifiers
SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0. BNF code shown is the factual mapping value distributed by NHS Business Services Authority (NHSBSA) in the dm+d supplementary file under OGL v3.0; it is not affiliated with, nor licensed from, the publishers of the British National Formulary.
Active and completed clinical studies from ClinicalTrials.gov
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.
Academic studies and reviews for this medicine's active substance
Showing the 50 most relevant studies.
Reviews & meta-analyses: 3 · Randomised trials: 1 · 2000–2026
Showing the 50 most relevant studies, sorted by most relevant.
Indian Journal of Traditional Knowledge, 2025
F Dantas, H Rampes
British Homeopathic Journal, 2000
L Long, E Ernst
British Homeopathic Journal, 2001
David Brulé, Lauren Sule, Beth Landau-Halpern, et al.
Complementary Medicine Research, 2014
- Attention Deficit Disorder with Hyperactivity
- Materia Medica
- Pilot Projects
İsmail ACAR, Ayten DİZKIRICI
Anatolian Journal of Botany, 2023
The Agaricaceae is a monophyletic group of saprotrophic fungi distributed worldwide. The family exhibits considerable variations such as spore color and structure of pileus covering in morphology. Agaricus is the type genus of the family containing both edible and poisonous species, with more than 500 species worldwide. This genus includes many species that are considerably important so takes attention of scientists in the fields of medicine, biochemistry and food science. This study aims to introduce a new record, Agaricus micromegethus, for the Turkish mycobiota based on macro- and micromorphology. An illustrated description of the record is provided.
Abstract licence: CC BY
Zoltan Erdos, David John Studholme, Ben Raymond, et al.
Access Microbiology, 2023
The entomopathogenic fungus Akanthomyces muscarius is commonly used in agriculture to manage insect pests. Besides its use as a commercially important biological control agent, it also presents a potential model for studying host–pathogen interactions and the evolution of virulence in a laboratory setting. Here, we describe the first high-quality genome sequence for A. muscarius . We used long- and short-read sequencing to assemble a sequence of 36.1 Mb with an N 50 of 4.9 Mb. Genome annotation predicted 12347 genes, with 96.6 % completeness based on the core Hypocrealen gene set. The high-quality assembly and annotation of A. muscarius presented in this study provides an essential tool for future research on this commercially important species.
Abstract licence: CC BY 4.0
Fatih KUTLUER
Uluslararası Muhendislik Arastirma ve Gelistirme Dergisi, 2023
Oğuzhan Kaygusuz, Meryem Şenay Şengül Demirak
Anatolian Journal of Botany, 2025
Agaricus parvitigrinus, a member of Agaricus section Xanthodermatei, was collected under Pinus brutia in western Türkiye and is presented and illustrated here as a new record based on its morphological characteristics and molecular analyses of the nuclear rDNA internal transcribed spacer (ITS1-5.8S-ITS2 = ITS) region. A comprehensive description, color photographs, line drawings of microscopic features, and comparisons with phenotypically similar taxa and phylogenetically related species are provided.
Abstract licence: CC BY
Soto-Sánchez J, Garza-Treviño G
2024
Zoltan Erdos, David John Studholme, Ben Raymond, et al.
2023
The entomopathogenic fungus Akanthomyces muscarius is commonly used in agriculture to manage insect pests. Besides its use as a commercially important biological control agent, it also presents a potential model for studying host-pathogen interactions and virulence evolution in a laboratory setting. Here, we describe the first high-quality genome sequence for A. muscarius. We used long- and short-read sequencing to assemble a sequence of 36.1 Mb with an N50 of 4.9 Mb. Genome annotation predicts 12,347 genes, with 96.6 % completeness based on the core Hypocrealen gene set (Benchmarking Universal Single-Copy Orthologs). The high-quality assembly and annotation of A. muscarius presented in this study provide an essential tool for future research on this commercially important species.
Abstract licence: CC BY 4.0
Sources: aggregated from Europe PMC (EMBL-EBI), OpenAlex, Crossref, PubMed and other open scholarly databases. Retracted articles are excluded. Study information is provided for research purposes and does not constitute medical advice.
Scientific data (pharmacology, interactions, ADME) is not yet available for this medicine. Clinical sections are sourced from the NHS dm+d database.